Skip to main content
Premium Trial:

Request an Annual Quote

Fool Me Once…

In The Scientist PNNL's Steven Wiley explains why he's sat out the mad rush for Challenge Grants. "Although the intent is good, history suggests that these grants will eventually be looked upon as one of the greatest time wasters of the decade," he writes. In the '90s, he says there was a similar rush for funding from the US Army Breast Cancer Research Program and for that his area of research was only funded at four percent -- "much less than the NIH payline."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.